Beaumont Quantitative Lung Function Imaging to Characterize Patients With SARS-COV 2
COVID CT, Beaumont Quantitative Lung Function Imaging to Characterize Patients With SARS-COV 2
Sponsor: Corewell Health East
Terminated
staffing shortage and resource prioritization
Other terminated trials from Corewell Health East
A observational or N/A phase clinical study on COVID-19 and SARS-COV2, this trial is terminated or withdrawn. The trial is conducted by Corewell Health East and has accumulated 10 data snapshots since 2020. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
10 versions recorded-
Jan 2026 — Present [monthly]
Terminated
-
Sep 2024 — Jan 2026 [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Feb 2022 — Jul 2024 [monthly]
Terminated
Status: Recruiting → Terminated
-
Sep 2021 — Feb 2022 [monthly]
Recruiting
▶ Show 5 earlier versions
-
May 2021 — Sep 2021 [monthly]
Recruiting
-
Jan 2021 — May 2021 [monthly]
Recruiting
-
Aug 2020 — Jan 2021 [monthly]
Recruiting
-
Jun 2020 — Aug 2020 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Apr 2020 — Jun 2020 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Corewell Health East
For direct contact, visit the study record on ClinicalTrials.gov .